🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fosamprenavir

Found 67 matching trials

"The Once A Day Protease Inhibitor Regimens"

PHASE4

Atazanavir (ATV) and fosamprenavir (fAPV) are new protease inhibitors that ...

Status

Completed

Location

Thomas Street Health Center

Start Date

2004-05

Trial ID

NCT00242216

Treatments Being Tested

ritonavir-boosted atazanavir ritonavir-boosted fosamprenavir

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

PHASE3

The purpose of this study is to test 2 different dosing regimens of GW43390...

Status

Unknown

Location

Phoenix Body Positive

Start Date

2001-05

Trial ID

NCT00025727

Treatments Being Tested

Lopinavir/Ritonavir Ritonavir GW433908

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

PHASE2

The goal of this clinical study is to learn more about the effects of switc...

Status

Active Not Recruiting

Location

Be Well Medical Center

Start Date

2022-08-16

Trial ID

NCT05502341

Treatments Being Tested

Bictegravir Lenacapavir BIC/LEN FDC Stable Baseline Regimen

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

PHASE1

The purpose of this study is to characterise the pharmacokinetic profiles o...

Status

Completed

Location

Germans Trias i Pujol Hospital

Start Date

2005-01

Trial ID

NCT00307502

Treatments Being Tested

Nevirapine Efavirenz Indinavir/ritonavir Nelfinavir Saquinavir/ritonavir Lopinavir/ritonavir Atazanavir Atazanavir/ritonavir Fos-amprenavir/ritonavir Tipranavir/ ritonavir Darunavir/ritonavir

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

PHASE1

The primary objectives are to determine the effect of steady-state DRV/rtv ...

Status

Completed

Location

Multiple Locations

Start Date

2008-06

Trial ID

NCT00775125

Treatments Being Tested

Telaprevir; Darunavir; Ritonavir; Fosamprenavir

MARCH Central Nervous System Substudy

N/A

This substudy is a prospective, observational, open-label, randomised study...

Status

Completed

Location

Fundación IDEAA

Start Date

2012-06

Trial ID

NCT01637233

Treatments Being Tested

Arm 1 TNucleotide Analogue Reverse Transcriptase Inhibitors and Boosted Protease Inhibitors Arm 2 Maraviroc and Protease Inhibitors Arm 3 Maraviroc and Nucleotide Analogue Reverse Transcriptase Inhibitors

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

PHASE3

This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...

Status

Completed

Location

Spectrum Medical Group

Start Date

2011-11

Trial ID

NCT01475838

Treatments Being Tested

PI RTV FTC/TDF Stribild

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

PHASE3

The purpose of this randomized, open-label, multicenter, active-controlled ...

Status

Completed

Location

University of Alabama - Birmingham

Start Date

2010-11

Trial ID

NCT01252940

Treatments Being Tested

FTC/RPV/TDF PI RTV NRTIs

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

PHASE4

In subjects on boosted protease inhibitor (PI)-regimens who have elevated t...

Status

Completed

Location

Franco Felizarta, MD

Start Date

2009-09

Trial ID

NCT01010399

Treatments Being Tested

Lovaza fosamprenavir/ritonavir

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

PHASE4

This study examines the impact of fosamprenavir as part of an ART on virolo...

Status

Completed

Location

Hospital Príncipe de Asturias

Start Date

2011-03

Trial ID

NCT01222611

Treatments Being Tested

Fosamprenavir

Previous Next